Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

2013649 citationsJournal Article

Authors

Richard M. Bergenstal · Park Nicollet Clinic

David C. Klonoff · Mills Peninsula Health Services

Satish K. Garg · University of Colorado Denver

Bruce W. Bode · Atlanta Diabetes Associates

Melissa Meredith · University of Wisconsin–Madison

Robert H. Slover · University of Colorado Denver

Andrew Ahmann

Abstract

This study showed that over a 3-month period the use of sensor-augmented insulin-pump therapy with the threshold-suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values. (Funded by Medtronic MiniMed; ASPIRE ClinicalTrials.gov number, NCT01497938.).

Topics & Keywords

Diabetes Management and Research Pancreatic function and diabetes Diabetes Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 369, Issue 3, pp. 224-232

DOI: 10.1056/nejmoa1303576

Field-Weighted Citation Impact: 48.19